Pages that link to "Q40707798"
Jump to navigation
Jump to search
The following pages link to Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery (Q40707798):
Displaying 24 items.
- In situ transduction of target cells on solid surfaces by immobilized viral vectors (Q24800547) (← links)
- Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects (Q28247202) (← links)
- Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin (Q33307618) (← links)
- The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro (Q33697191) (← links)
- Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase (Q34128115) (← links)
- Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. (Q35019399) (← links)
- Engineering biomaterial systems to enhance viral vector gene delivery (Q35144415) (← links)
- Controlled release systems for DNA delivery (Q35826516) (← links)
- Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells (Q35952192) (← links)
- Gene Delivery by Immobilization to Cell-Adhesive Substrates (Q37137872) (← links)
- Magnetic targeting strategies in gene delivery (Q37955213) (← links)
- The evolution of adenoviral vectors through genetic and chemical surface modifications (Q38189250) (← links)
- Directional gene-transfer into the brain by an adenoviral vector tagged with magnetic nanoparticles (Q39632274) (← links)
- Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation (Q40349546) (← links)
- Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells (Q40367980) (← links)
- Chemically inactivated adenoviral vectors that can efficiently transduce target cells when delivered in the form of virus-microbead conjugates. (Q40459996) (← links)
- Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration (Q41992397) (← links)
- Generation of magnetic nonviral gene transfer agents and magnetofection in vitro (Q43419330) (← links)
- Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression (Q44477381) (← links)
- Localized viral vector delivery to enhance in situ regenerative gene therapy. (Q45866516) (← links)
- Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo (Q45875626) (← links)
- Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors. (Q51857382) (← links)
- Designer Oncolytic Adenovirus: Coming of Age. (Q55467684) (← links)
- Biopolymers augment viral vectors based gene delivery (Q90013444) (← links)